SHENZHEN, CHINA, 28th, September 2021-The COVID-19 pandemic remains severe and complex in many parts of Southeast Asia and beyond, posing a formidable challenge to the public health system. Diagnostic testing remains to be crucial in fighting against the COVID-19 pandemic. As an important measure for the COVID-19 control and prevention, how to improve the capacity of nucleic acid detection has attracted great attention from all countries. MGI, a world-leading life science technology innovator, ...

Shenzhen, China, 27 August 2021 - MGI and Molbreeding Biotech Co., Ltd. (Molbreeding) officially formed strategic cooperation in Molecular Breeding. Under the partnership, the two parties will join hands to develop more molecular breeding applications and products based on MGI's DNBSEQ-T7 ultra-high throughput sequencing platform, to promote the innovation and industrialization of animal and plant molecular breeding in China. Enhancing genetic detection capacity with lower cost to improve the ...

MGIUS-R3 Robotic Ultrasound System was selected for 17 pilot projects covering 4 categories including 5G+Emergency Treatment, 5G+Remote Diagnosis, 5G+Remote ICU and 5G+Healthcare Management. 5G + Emergency Treatment●Under this Category, the MGI system was successfully selected for the 5G+ Plateau emergency treatment project. 5G+Remote Diagnosis●Under the 5G+ Remote Diagnosis category, MGI system was selected for a total of 14 5G+ Remote Ultrasound Robot related projects that were initiated b...

On August 10, China Health Commission issued Notice on Further Strengthening the Organization and Management of Nucleic Acid Testing for All Staff (the Notice) in response to the COVID-19 pandemic control and prevention. "We have greatly upgraded the performance of automation equipment and accumulated extensive frontline experience, making it possible to provide urgent support for large-scale nucleic acid testing." Lin Siyuan, Director of Mobile Lab at MGI. "It will take 42 MGISTP-7000 High-th...

MGI's proprietary automation systems have supported the outbreaks in more than 23 cities in China to date. In addition, MGI production team from Shenzhen and Qingdao have gathered to MGI Wuhan to support the production of automation equipment, ensuring the large-scale nucleic acid testing in various places. MGI production team set out to support the outbreak in Wuhan On August 1st, MGI urgently deployed 8 Container Labs from other cities to Changsha, Hunan Province. Through multi-party coordi...

BRISBANE, AUSTRALIA, 29 JUL 2021 – MGI, a world-leading life science technology innovator, announces the opening of MGI Australia Demonstration Laboratory (Demo Lab) to support the users in Asia-Pacific (APAC). The lab is dedicated to offering the APAC researchers and users unique access to MGI's cutting-edge technology portfolio including DNBSEQ platforms*, laboratory automation systems and bioinformatics products, for application development, technology assessment and technical support. MGI A...